New proton beam device tested for safer cancer treatment

NCT ID NCT07152353

Ongoing Disease control Sponsor: Ion Beam Applications Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This trial is testing a new proton beam therapy device called PROTEUS® PLUS for treating solid tumors in adults. 47 participants will receive radiation from this machine to see if it is safe and effective at controlling tumors. The goal is to gather data for product registration and potentially offer a more precise treatment option.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Proton beam therapy (PROTEUS® PLUS device)
What this could lead to: If successful, this could provide a safer, more precise radiation option for treating various solid tumors, potentially reducing side effects compared to standard radiation.
What could go wrong: This is an early-stage device trial with only 47 participants, so results may not apply to all patients. Proton therapy is not new, and this specific system may not prove safer or more effective than existing options. Side effects from radiation, including toxicity, are still possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTRACRANIAL TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

brain neoplasm neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SOLID TUMOR, ADULT

Contacts and locations

Locations

Sichuan Cancer Hospital & Institute

Chengdu, Sichuan, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.